nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.0055	0.101	CrCbGaD
Triflupromazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.00353	0.0647	CrCbGaD
Triflupromazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.00345	0.0632	CrCbGaD
Triflupromazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.00331	0.0606	CrCbGaD
Triflupromazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.00283	0.0518	CrCbGaD
Triflupromazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.00282	0.0517	CrCbGaD
Triflupromazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.00253	0.0463	CrCbGaD
Triflupromazine—Promazine—ADRA1D—polycystic ovary syndrome	0.00245	0.0449	CrCbGaD
Triflupromazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.00241	0.0442	CrCbGaD
Triflupromazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.00238	0.0435	CrCbGaD
Triflupromazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.00232	0.0426	CrCbGaD
Triflupromazine—Imipramine—ADRA1D—polycystic ovary syndrome	0.00215	0.0393	CrCbGaD
Triflupromazine—Promazine—ADRA1B—polycystic ovary syndrome	0.00209	0.0383	CrCbGaD
Triflupromazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.0019	0.0348	CrCbGaD
Triflupromazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.00184	0.0337	CrCbGaD
Triflupromazine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00183	0.0335	CrCbGaD
Triflupromazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.0017	0.0312	CrCbGaD
Triflupromazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.00162	0.0298	CrCbGaD
Triflupromazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.0016	0.0293	CrCbGaD
Triflupromazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.00158	0.0289	CrCbGaD
Triflupromazine—Promazine—ADRA1A—polycystic ovary syndrome	0.00141	0.0258	CrCbGaD
Triflupromazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.00124	0.0227	CrCbGaD
Triflupromazine—Imipramine—ADRA1A—polycystic ovary syndrome	0.00123	0.0226	CrCbGaD
Triflupromazine—Desipramine—ADRB2—polycystic ovary syndrome	0.000864	0.0158	CrCbGaD
Triflupromazine—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000216	0.000228	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000215	0.000227	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000213	0.000226	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.000212	0.000225	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000212	0.000224	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000211	0.000224	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000211	0.000223	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000211	0.000223	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—INSR—polycystic ovary syndrome	0.00021	0.000222	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00021	0.000222	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000207	0.000219	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000206	0.000218	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000206	0.000218	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000205	0.000217	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000204	0.000216	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000204	0.000215	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000201	0.000212	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	0.0002	0.000212	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.0002	0.000211	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000199	0.00021	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000198	0.00021	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000198	0.00021	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000198	0.000209	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000197	0.000208	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000196	0.000207	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000196	0.000207	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000195	0.000207	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000195	0.000206	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.000195	0.000206	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000195	0.000206	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000195	0.000206	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000193	0.000204	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000193	0.000204	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000192	0.000203	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000191	0.000202	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000191	0.000202	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000191	0.000202	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000189	0.000199	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000189	0.000199	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000188	0.000199	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000187	0.000197	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000186	0.000197	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000186	0.000197	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000185	0.000196	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000185	0.000195	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000184	0.000195	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000184	0.000195	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—TH—polycystic ovary syndrome	0.000184	0.000194	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000184	0.000194	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000183	0.000193	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000181	0.000191	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000181	0.000191	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000181	0.000191	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000181	0.000191	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00018	0.000191	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000179	0.000189	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.000179	0.000189	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000179	0.000189	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000178	0.000189	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000178	0.000188	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000177	0.000187	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000177	0.000187	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000175	0.000185	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000174	0.000185	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000174	0.000185	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000174	0.000184	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000173	0.000183	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000171	0.000181	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000171	0.000181	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000171	0.000181	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000171	0.000181	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00017	0.00018	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000169	0.000178	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000168	0.000178	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.000168	0.000178	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000168	0.000178	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000168	0.000177	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000167	0.000177	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000167	0.000176	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000166	0.000176	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000166	0.000176	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000166	0.000175	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000166	0.000175	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000164	0.000174	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000164	0.000174	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000164	0.000173	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000163	0.000172	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000162	0.000171	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000159	0.000169	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000159	0.000168	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000159	0.000168	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000158	0.000168	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000158	0.000167	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000158	0.000167	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000158	0.000167	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000157	0.000166	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000156	0.000165	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000155	0.000164	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000153	0.000162	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000153	0.000162	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000152	0.000161	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000151	0.00016	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00015	0.000159	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GNAS—polycystic ovary syndrome	0.00015	0.000159	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00015	0.000158	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.00015	0.000158	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000149	0.000158	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000149	0.000158	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000147	0.000155	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000145	0.000153	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000144	0.000153	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000144	0.000152	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000143	0.000151	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000142	0.00015	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000141	0.000149	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000141	0.000149	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00014	0.000148	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000139	0.000147	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000139	0.000147	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000139	0.000147	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000137	0.000145	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000137	0.000145	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000137	0.000145	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000136	0.000143	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000136	0.000143	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000135	0.000143	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000134	0.000142	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000132	0.00014	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000131	0.000139	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00013	0.000137	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000129	0.000136	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000129	0.000136	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000126	0.000134	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000126	0.000133	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000126	0.000133	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000126	0.000133	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000125	0.000132	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000124	0.000132	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000124	0.000132	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000124	0.000131	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000123	0.00013	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000122	0.00013	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000122	0.000129	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000121	0.000129	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00012	0.000127	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00012	0.000127	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00012	0.000127	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000119	0.000126	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000119	0.000126	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000118	0.000124	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000117	0.000124	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000117	0.000124	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000116	0.000123	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000115	0.000122	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000113	0.00012	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000113	0.000119	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000113	0.000119	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000112	0.000119	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000112	0.000118	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000111	0.000118	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000111	0.000117	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00011	0.000117	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00011	0.000116	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00011	0.000116	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000109	0.000115	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000109	0.000115	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000109	0.000115	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000108	0.000115	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000107	0.000113	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000106	0.000112	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000105	0.000111	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000105	0.000111	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000105	0.000111	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000104	0.00011	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000104	0.00011	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000103	0.000109	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000103	0.000109	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PPARG—polycystic ovary syndrome	0.000102	0.000108	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—POMC—polycystic ovary syndrome	0.000101	0.000107	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—INS—polycystic ovary syndrome	0.0001	0.000106	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	9.89e-05	0.000105	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	9.71e-05	0.000103	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	9.68e-05	0.000102	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	9.56e-05	0.000101	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.42e-05	9.97e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	9.35e-05	9.89e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	9.3e-05	9.84e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	9.25e-05	9.78e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.22e-05	9.75e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.16e-05	9.69e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.1e-05	9.63e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.05e-05	9.57e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	9e-05	9.52e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	8.99e-05	9.51e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.97e-05	9.49e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	8.93e-05	9.45e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	8.82e-05	9.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	8.77e-05	9.28e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	8.73e-05	9.23e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.54e-05	9.04e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.48e-05	8.97e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.48e-05	8.97e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8.2e-05	8.68e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.06e-05	8.52e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.92e-05	8.38e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.75e-05	8.2e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	7.75e-05	8.2e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.65e-05	8.1e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	7.59e-05	8.03e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	7.49e-05	7.92e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.32e-05	7.74e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.98e-05	7.38e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.92e-05	7.32e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	6.88e-05	7.28e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.77e-05	7.16e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.68e-05	7.07e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	6.66e-05	7.04e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	6.62e-05	7.01e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.61e-05	6.99e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	6.52e-05	6.89e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.49e-05	6.86e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	6.48e-05	6.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	6.43e-05	6.81e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.41e-05	6.78e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.4e-05	6.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	6.4e-05	6.77e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.27e-05	6.63e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.26e-05	6.63e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.19e-05	6.55e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.18e-05	6.54e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.16e-05	6.52e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.08e-05	6.43e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.95e-05	6.3e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.88e-05	6.22e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.88e-05	6.22e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.54e-05	5.86e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5e-05	5.29e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.93e-05	5.21e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.9e-05	5.19e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.9e-05	5.18e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.79e-05	5.07e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.73e-05	5.01e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.18e-05	4.43e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.1e-05	4.33e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	4.06e-05	4.3e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.04e-05	4.28e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	3.83e-05	4.05e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	2.89e-05	3.06e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.83e-05	3e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.8e-05	2.96e-05	CbGpPWpGaD
